Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

103.00p
   
  • Change Today:
      2.60p
  • 52 Week High: 110.00
  • 52 Week Low: 75.00
  • Currency: UK Pounds
  • Shares Issued: 538.04m
  • Volume: 864,074
  • Market Cap: £554.19m
  • RiskGrade: 119
  • Beta: 0.20

Latest Deals

Traded Action Notifier PriceAmountValue
19-Nov-21 Sell Peter Butterfield 102.50p 269,417 £276,152.42
19-Nov-21 Exercise of option Peter Butterfield 47.50p 500,000 £237,500.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
19-Nov-21 Sell Peter Butterfield 102.50p 269,417 £276,152.42
19-Nov-21 Exercise of option Peter Butterfield 47.50p 500,000 £237,500.00

Director Shareholdings

Notifier Holding Value*
Peter Butterfield 672,687 £692,868
David Cook 234,129 £241,153
Andrew Franklin 128,384 £132,236
Richard Jones 15,000 £15,450

Major Shareholders

Notifier** Holding Value*
FMR LLC 48,447,412 £49,900,834
MVM Life Science Partners 40,561,900 £41,778,757
Slater Investments Ltd 33,842,038 £34,857,299
Blackrock, Inc. 31,870,145 £32,826,249
Kempen Capital Management N.V. 26,621,969 £27,420,628
GVQ Investment Management Ltd 23,691,460 £24,402,204
Artemis Investment Management LLP 22,729,452 £23,411,336
John Dawson 18,876,402 £19,442,694
Aviva plc & its subsidiaries 18,255,256 £18,802,914
Royal Bank of Canada 17,534,588 £18,060,626
Stella Anne Dawson 15,576,323 £16,043,613
Investec Asset Management 7,750,000 £7,982,500
Old Mutual Asset Managers (UK) Ltd 7,488,920 £7,713,588

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 103.00p
Change Today 2.60p
% Change 2.59 %
52 Week High 110.00
52 Week Low 75.00
Volume 864,074
Shares Issued 538.04m
Market Cap £554.19m
Beta 0.20
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.8% below the market average85.8% below the market average85.8% below the market average85.8% below the market average85.8% below the market average
28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average
Price Trend
59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Income
50% below the market average50% below the market average50% below the market average50% below the market average50% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Growth
13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 03-Dec-2021

Time Volume / Share Price
16:37 150,000 @ 102.43p
16:37 150,000 @ 102.43p
16:40 16,675 @ 102.43p
16:35 156,651 @ 103.00p
16:29 18 @ 101.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page